Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
TNFRSF6B belongs to the tumor necrosis factor receptor superfamily. De plus, nous expédions TNFRSF6B Protéines (10) et TNFRSF6B Kits (9) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 81 products:
Human Monoclonal TNFRSF6B Primary Antibody pour IHC (p), ELISA - ABIN563778
Wu, Huang, Hsieh, Hsiao, Lee, Lin: EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis. dans Biochimica et biophysica acta 2013
Compared with the control, miR (Montrer MLXIP Anticorps)-340 was significantly lower in the serum of hepatocellular carcinoma patients (p<0.01). miR (Montrer MLXIP Anticorps)-340 was lower in HCC (Montrer FAM126A Anticorps) tissues than in adjacent; however, DcR3, TGF-beta1 (Montrer TGFB1 Anticorps) and Smad2 (Montrer SMAD2 Anticorps) were higher.
DcR3 treatment caused HepG2 cell cytoskeleton remodeling, inhibited E-cadherin (Montrer CDH1 Anticorps) expression, and promoted cell migration.
DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma risk in Northeast Chinese females
Study found that both transcriptional expression and post-transcriptional DcR3 expression DcR3 expression were significantly up-regulated in colorectal cancer (CRC (Montrer CALR Anticorps)) tissues. DcR3 was found to be playing a critical role in CRC (Montrer CALR Anticorps) proliferation and migration in vitro and in tumorigenesis and metastasis in vivo.
Higher plasma DcR3 level was related to better coronary collateral circulation (CCC) formation and displayed potent predictive power for CCC status in patients with coronary artery disease.
High serum DcR3 levels are associated with disease severity in nonatopic asthma patients.
Results show that DcR3 engages TNF (Montrer TNF Anticorps) ligands: FasL (Montrer FASL Anticorps), LIGHT, and TL1A (Montrer TNFSF15 Anticorps) in a structurally similar fashion and its promiscuity is due to recognition of backbone atoms and invariant side chains.
These results raise the possibility for involvement of TL1A (Montrer TNFSF15 Anticorps)/DR3/DR3 (Montrer TNFRSF25 Anticorps)-mediated mechanisms in epithelial-mesenchymal interactions and the development of inflammation-induced intestinal fibrosis in Crohn's disease.
when idiopathic pulmonary fibrosis cells interact with collagen matrix, aberrantly activated Akt (Montrer AKT1 Anticorps) increases DcR3 expression via GSK-3beta-NFATc1 (Montrer NFATC1 Anticorps) and protects IPF cells from the FasL (Montrer FASL Anticorps)-dependent apoptotic pathway.
Coexpression of TNFRSF6B and PCDHGA3 (Montrer PCDHgA3 Anticorps) was observed immunohistochemically in FL18 cells, suggesting potential cooperation in tumor cell maintenance.
This gene belongs to the tumor necrosis factor receptor superfamily. The encoded protein is postulated to play a regulatory role in suppressing FasL- and LIGHT-mediated cell death. It acts as a decoy receptor that competes with death receptors for ligand binding. Over-expression of this gene has been noted in gastrointestinal tract tumors. Read-through transcription into this gene from the neighboring upstream gene, which encodes regulator of telomere elongation helicase 1 (RTEL1), generates a non-coding transcript.
decoy receptor 3
, decoy receptor for Fas ligand
, tumor necrosis factor receptor superfamily member 6B
, tumor necrosis factor receptor superfamily, member 6b
, tumor necrosis factor receptor superfamily, member 6b, decoy